Treatment for Cancer Newly Developed in the Remnant Stomach―Surgical Therapy Nobuhiko Tanigawa 1 , Eiji Nomura 1 , Hideaki Mabuchi 1 1Department of General and Gastroenterological Surgery, Osaka Medical College Keyword: 残胃癌 , 初回良性群 , 初回悪性群 , 下縦隔リンパ節転移 , 空腸間膜リンパ節転移 pp.1043-1048
Published Date 2004/6/25
DOI https://doi.org/10.11477/mf.1403100526
  • Abstract
  • Look Inside
  • Reference

 Cancer in the remnant stomach after partial gastrectomy(CRS)attracts interests not only as a typical model in the study of carcinogenesis, but also under the aspect of cancer diagnosis. During the last26years we have had experience in treating60patients with CRS. Clinicopathological variables and postoperative survivals were reviewed to clarify whether there are any common characteristics of this disease. Results and Conclusion :1)The mean time interval between the initial and second surgeries was shorter in patients with previous cancer.2)An early stage of CRS is more frequent in patients with previous cancer or in those with reconstruction by the Billroth I method.3)CRS with a differentiated histology developed more frequently in patients with previous cancer.4)Long-term survivals of CRS were comparable to a certain extent with those of primary cancer in the upper stomach.5)Prevalence of the development of lymph node metastasis in the lower mediastinum or the jejunal mesentery is one of the unique features of CRS.

 1) Department of General and Gastroenterological Surgery, Osaka Medical College, Takatsuki, Japan

Copyright © 2004, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1219 印刷版ISSN 0536-2180 医学書院